INCREASED TURNOVER OF VERY LOW-DENSITY-LIPOPROTEIN TRIGLYCERIDE DURING TREATMENT WITH CHOLESTYRAMINE IN FAMILIAL HYPERCHOLESTEROLEMIA

被引:29
作者
ANGELIN, B
LEIJD, B
HULTCRANTZ, R
EINARSSON, K
机构
[1] Metabolism Unit, Department of Medicine, Karolinska Institutet at Huddinge University Hospital, Huddinge
关键词
cholesterol; cholestyramine; familial hypercholesterolaemia; lipoprotein turnover; triglyceride; very low density lipoprotein;
D O I
10.1111/j.1365-2796.1990.tb00143.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abstract. Kinetics of very low density lipoprotein (VLDL) triglyceride were determined in seven patients with heterozygous familial hypercholesterolaemia, using a 3H‐glycerol technique. The study was repeated after 5–7 weeks of therapy with the bile acid‐binding resin, cholestyramine. The rate of synthesis of VLDL triglyceride was increased by 85% (P < 0.05) during resin therapy. Simultaneously, the fractional catabolic rate of VLDL was increased by 40% (P < 0.02), so that only a moderate increase in plasma concentration was observed. Repeated measurements of VLDL size by electron microscopy (before, 1 week, and 5–7 weeks after initiation of therapy) indicated that a transient increase in VLDL size occurred in response to cholestyramine. The results are consistent with a stimulatory effect of bile acid sequestrants on VLDL triglyceride production and indicate that, in most subjects, a compensatory increase in VLDL triglyceride removal occurs. 1990 Blackwell Publishing Ltd
引用
收藏
页码:201 / 206
页数:6
相关论文
共 50 条
[31]   EFFECTS OF PRAVASTATIN SODIUM ALONE AND IN COMBINATION WITH CHOLESTYRAMINE ON HEPATIC, INTESTINAL AND ADRENAL LOW-DENSITY-LIPOPROTEIN RECEPTORS IN HOMOZYGOUS WATANABE HERITABLE HYPERLIPIDEMIC RABBITS [J].
KURODA, M ;
MATSUMOTO, A ;
ITAKURA, H ;
WATANABE, Y ;
ITO, T ;
SHIOMI, M ;
FUKUSHIGE, J ;
NARA, F ;
FUKAMI, M ;
TSUJITA, Y .
JAPANESE JOURNAL OF PHARMACOLOGY, 1992, 59 (01) :65-70
[32]   Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality [J].
Miwa, Y ;
Mitsuzumi, H ;
Sunayama, T ;
Yamada, M ;
Okada, K ;
Kubota, M ;
Chaen, H ;
Mishima, Y ;
Kibata, M .
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2005, 51 (06) :460-470
[33]   An increased number of very-low-density lipoprotein particles is strongly associated with coronary heart disease in Japanese men, independently of intermediate-density lipoprotein or low-density lipoprotein [J].
Koba, S ;
Hirano, T ;
Sakaue, T ;
Takeuchi, H ;
Adachi, M ;
Katagiri, T .
CORONARY ARTERY DISEASE, 2002, 13 (05) :255-262
[34]   Effect of feeding psyllium and cholestyramine in combination on low density lipoprotein metabolism and fecal bile acid excretion in hamsters with dietary-induced hypercholesterolemia [J].
Turley, SD ;
Daggy, BP ;
Dietschy, JM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 27 (01) :71-79
[35]   Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study [J].
Beheshti, Sabina ;
Madsen, Christian M. ;
Varbo, Anette ;
Benn, Marianne ;
Nordestgaard, Borge G. .
CIRCULATION, 2018, 138 (06) :578-589
[36]   CRISPR Correction of a Homozygous Low-Density Lipoprotein Receptor Mutation in Familial Hypercholesterolemia Induced Pluripotent Stem Cells [J].
Omer, Linda ;
Hudson, Elizabeth A. ;
Zheng, Shirong ;
Hoying, James B. ;
Shan, Yuan ;
Boyd, Nolan L. .
HEPATOLOGY COMMUNICATIONS, 2017, 1 (09) :886-898
[37]   Duplication of exon 7-12 in the low-density Lipoprotein receptor gene in three Danish patients with familial hypercholesterolemia [J].
Feddersen, Soren ;
Overgaard, Martin ;
Nybo, Mads .
JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (02) :174-177
[38]   Low-Density Lipoprotein Cholesterol Level Distributions Across Different Ages: Implications for Screening Children for Severe and Familial Hypercholesterolemia [J].
Liu, Junxiu ;
Bellows, Brandon K. ;
Jacobs, David R. ;
Woo, Jessica G. ;
Urbina, Elaine M. ;
Balte, Pallavi P. ;
Oelsner, Elizabeth C. ;
Kazi, Dhruv S. ;
Siscovick, David ;
Allen, Norrina B. ;
Rana, Jamal S. ;
Wilkins, John T. ;
Hall, Michael E. ;
Bazzano, Lydia A. ;
Burns, Trudy L. ;
Daniels, Stephen R. ;
Dwyer, Terence ;
Juonala, Markus ;
Raitakari, Olli T. ;
Sinaiko, Alan R. ;
Steinberger, Julia ;
Venn, Alison J. ;
Kartiosuo, Noora ;
Lehtimaki, Terho ;
Magnussen, Costan G. ;
Viikari, Jorma S. A. ;
de Ferranti, Sarah D. ;
Moran, Andrew E. ;
Zhang, Yiyi .
CIRCULATION, 2024, 150 (21) :1741-1744
[39]   Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects [J].
Lambert, Gilles ;
Petrides, Francine ;
Chatelais, Mathias ;
Blom, Dirk J. ;
Choque, Benjamin ;
Tabet, Fatiha ;
Wong, Gida ;
Rye, Kerry-Anne ;
Hooper, Amanda J. ;
Burnett, John R. ;
Barter, Philip J. ;
Marais, A. David .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (22) :2365-2373
[40]   Relationship between plasma fenofibric acid levels and the effect of micronized fenofibrate on cholesterol, low-density-lipoprotein cholesterol and apolipoprotein B in patients with primary hypercholesterolemia [J].
Raslova, K ;
Dubovska, D ;
Mongiellova, V ;
Trnovec, T .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (02) :101-106